Revelation Biosciences annual total assets
2019
2020
2021
2022
2023
2024
2025
Revelation Biosciences Total Assets Growth & History (REVB)
Revelation Biosciences's total assets was $11.6M for fiscal 2025.
View full Revelation Biosciences company overviewRevelation Biosciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.6M | $5.0M | +74.91% |
| 2024 | 2024-12-31 | $6.6M | −$5.6M | −45.78% |
| 2023 | 2023-12-31 | $12.2M | $6.7M | +121.91% |
| 2022 | 2022-12-31 | $5.5M | $3.5M | +169.48% |
| 2021 | 2021-12-31 | $2.0M | −$72.1M | −97.25% |
| 2020 | 2020-12-31 | $74.2M | $74.1M | +327023.66% |
| 2019 | 2019-12-31 | $22,671 | — | — |
Revelation Biosciences quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $12.5M | $7.1M | +131.65% |
| Q1 2026 | 2026-03-31 | $15.0M | $11.1M | +278.92% |
| Q4 2025 | 2025-12-31 | $11.6M | $5.0M | +74.91% |
| Q3 2025 | 2025-09-30 | $12.9M | $6.1M | +90.74% |
| Q2 2025 | 2025-06-30 | $5.4M | −$6.9M | −56.03% |
| Q1 2025 | 2025-03-31 | $4.0M | −$10.7M | −72.99% |
| Q4 2024 | 2024-12-31 | $6.6M | −$5.6M | −45.78% |
| Q3 2024 | 2024-09-30 | $6.7M | −$7.5M | −52.60% |
| Q2 2024 | 2024-06-30 | $12.3M | −$3.8M | −23.50% |
| Q1 2024 | 2024-03-31 | $14.7M | −$3.4M | −18.86% |
| Q4 2023 | 2023-12-31 | $12.2M | $6.7M | +121.91% |
| Q3 2023 | 2023-09-30 | $14.2M | $7.6M | +115.38% |
| Q2 2023 | 2023-06-30 | $16.0M | $11.9M | +286.11% |
| Q1 2023 | 2023-03-31 | $18.1M | $10.1M | +127.06% |
| Q4 2022 | 2022-12-31 | $5.5M | $3.5M | +169.48% |
| Q3 2022 | 2022-09-30 | $6.6M | −$67.0M | −91.03% |
| Q2 2022 | 2022-06-30 | $4.2M | −$69.7M | −94.38% |
| Q1 2022 | 2022-03-31 | $8.0M | −$66.0M | −89.22% |
| Q4 2021 · Dec 31 | 2021-12-31 | $2.0M | −$72.1M | −97.25% |
| Q3 2021 | 2021-09-30 | $73.6M | $70.1M | +2002.15% |
| Q2 2021 | 2021-06-30 | $73.9M | — | — |
| Q1 2021 | 2021-03-31 | $74.0M | — | — |
| Q4 2020 | 2020-12-31 | $74.2M | $74.1M | +327023.66% |
| Q3 2020 | 2020-09-30 | $3.5M | — | — |
| Q4 2019 | 2019-12-31 | $22,671 | — | — |
Revelation Biosciences total assets trends
Over the last five fiscal years, Revelation Biosciences's total assets decreased from $74.2M to $11.6M, a change of −$62.6M. The latest reported quarter, Q2 2026, shows $12.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Revelation Biosciences source filings ↗